In Vitro and in Vivo Efficacy of Afatinib as a Single Agent or in Combination With Gemcitabine for The treatment of Nasopharyngeal Carcinoma

Drug Design, Development and Therapy - New Zealand
doi 10.2147/dddt.s94432
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Fasting Cycles Potentiate the Efficacy of Gemcitabine Treatment in in Vitro and in Vivo Pancreatic Cancer Models

Oncotarget
Oncology
2015English

Combination Treatment With Cetuximab in Advanced Nasopharyngeal Carcinoma Patients: A Meta-Analysis

OncoTargets and Therapy
OncologyPharmacology
2019English

Osthole Sensitizes With Radiotherapy to Suppress Tumorigenesis of Human Nasopharyngeal Carcinoma in Vitro and in Vivo

Cancer Management and Research
Oncology
2018English

STK405759 as a Combination Therapy With Bortezomib or Dexamethasone, in in Vitro and in Vivo Multiple Myeloma Models

Oncotarget
Oncology
2018English

A Case of Advanced Biliary Tract Cancer Successfully Treated With Single-Agent Gemcitabine Chemotherapy in Combination With Juzentaihoto

Kampo Medicine
2012English

Effects of Lentinan Alone and in Combination With Fluoropyrimidine Anticancer Agent on Growth of Human Oral Squamous Cell Carcinoma in Vitro and in Vivo

International Journal of Oncology
Cancer ResearchOncology
2010English

Commentary on “Gemcitabine: Single‐Agent and Combination Therapy in Non‐Small Cell Lung Cancer”

Oncologist
Cancer ResearchMedicineOncology
1999English

Pemetrexed and Gemcitabine as Combination Therapy for the Treatment of Group3 Medulloblastoma

Cancer Cell
Cancer ResearchOncologyCell Biology
2014English

Bioavailability of Triprolidine as a Single Agent or in Combination With Pseudoephedrine: A Randomized, Open‐Label Crossover Study in Healthy Volunteers

Clinical Pharmacology in Drug Development
PharmacologyPharmaceutical Science
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy